Literature DB >> 22955554

The Bolton Treovance abdominal stent-graft: European clinical trial design.

R Chiesa1, V Riambau, G Coppi, B Zipfel, S Llagostera, E M Marone, A Kahlberg.   

Abstract

Endovascular aortic repair (EVAR) has emerged as a promising, less invasive alternative to conventional open surgery for the treatment of infrarenal abdominal aortic aneurysms (AAAs). In the last 20 years, the application rate of EVAR and its clinical results have significantly improved thanks to the evolution of stent-grafts and endovascular delivery systems. However, further development is still needed to reduce the incidence of complications and secondary re-interventions. The Treovance abdominal aortic stent-graft (Bolton Medical, Barcelona, Spain) is a new-generation endovascular device, developed to increase flexibility, lower profile, improve deployment and sealing mechanisms. In particular, it is provided with some innovative features as a double layer of proximal barbs (suprarenal and infrarenal) for supplemental fixation, dull barbs between modules to avoid potential leg disconnections, detachable outer sheath provided with a new-design hemostatic valve, and a double improved mechanism (slow motion and "pin and pull") for precise stent-graft deployment. A European prospective, non-randomized, multi-institutional, "first-in-human" trial (the ADVANCE trial) was conducted from March to December 2011 to assess the safety and performance of the Treovance stent-graft system before commercialization. Thirty patients with anatomically suitable non-ruptured AAAs were enrolled at five clinical sites in Italy, Spain, and Germany. EVAR was completed successfully in all patients. The stent-graft was delivered and deployed safely even in heavily angulated or calcified anatomies. No 30-day device-related complications nor deaths were observed. Preliminary experience with the Treovance abdominal stent-graft within the ADVANCE trial was satisfactory with regard to technical success and perioperative clinical results. Follow-up data are needed to assess mid- and long-term clinical outcomes, along with durability of this new-generation endovascular device.

Entities:  

Mesh:

Year:  2012        PMID: 22955554

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  6 in total

Review 1.  A critical appraisal of endovascular stent-grafts in the management of abdominal aortic aneurysms.

Authors:  Nikolaos Schoretsanitis; Efstratios Georgakarakos; Christos Argyriou; Kiriakos Ktenidis; George S Georgiadis
Journal:  Radiol Med       Date:  2017-01-21       Impact factor: 3.469

Review 2.  Endografts for the treatment of abdominal aortic aneurysms with a hostile neck anatomy: A systematic review.

Authors:  Christos Pitros; Pietro Mansi; Stavros Kakkos
Journal:  Front Surg       Date:  2022-08-15

Review 3.  Current status of endovascular devices to treat abdominal aortic aneurysms.

Authors:  Kamell Eckroth-Bernard; Robert Garvin; Evan Ryer
Journal:  Biomed Eng Comput Biol       Date:  2013-04-10

4.  Non-Invasive Pulse Wave Analysis in a Thrombus-Free Abdominal Aortic Aneurysm after Implantation of a Nitinol Aortic Endograft.

Authors:  Efstratios Georgakarakos; Christos Argyriou; George S Georgiadis; Miltos K Lazarides
Journal:  Front Surg       Date:  2016-01-11

5.  Abdominal aorta aneurysm with hostile neck: Early outcomes in outside instruction for use in patients using the treovance® stent graft.

Authors:  Umberto G Rossi; Pierluca Torcia; Raffaello Dallatana; Davide Santuari; Pietro Mingazzini; Maurizio Cariati
Journal:  Indian J Radiol Imaging       Date:  2017 Oct-Dec

6.  Global Post-Market Clinical Follow-up of the Treovance Stent-Graft for Endovascular Aneurysm Repair: One-Year Results From the RATIONALE Registry.

Authors:  Raman Uberoi; Carlo Setacci; Mario Lescan; Antonio Lorido; David Murray; Zoltán Szeberin; Tomasz Zubilewicz; Vincent Riambau; Angsu Chartrungsan; Jörg Tessarek
Journal:  J Endovasc Ther       Date:  2018-10-03       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.